Ubs Group Ag Jaguar Health, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.08 - $809.55 $9,489 - $96 Million
118,613 New
118,613 $10,000
Q2 2022

Aug 10, 2022
BUY
$0.27 - $0.71 $10,459 - $27,505
38,740 New
38,740 $11,000

Others Institutions Holding JAGX

# of Institutions
2
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Jaguar Health, Inc.

JAGX Quotes by TradingView
  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $127M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email